Interactions between lipoteichoic acid and peptidoglycan from Staphylococcus aureus: A structural and functional analysis

Microbes and Infection

Volumn 4, Issue 9, 2002, Pages 927-935

  Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Lipoteichoic acid; Peptidoglycan; Shock

Indexed keywords

CD14 ANTIGEN; FC GAMMA RECEPTOR I; FC RECEPTOR; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOTEICHOIC ACID; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; MACROPHAGE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG SYNERGISM; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MULTIPLE ORGAN FAILURE; PEPTIDOGLYCAN; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

ANIMALIA; POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0036067701     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01620-9     Document Type: Review

References (52)

1. Gram-positive organisms and sepsis
2. Southwestern Internal Medicine Conference Septic Shock
3. Role of endotoxemia in cardiovascular dysfunction and mortality - Escherichia coli and S. aureus challenges in a canine model of human septic shock
4. S. epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock like state and tissue injury in rabbits without endotoxemia - Comparison to Escherichia coli
5. Physiology of lipoteichoic acids in bacteria
6. Lipid composition as a guide to the classification of bacteria
7. Structure and immunochemistry of peptidoglycan
8. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure
9. Molecular mechanisms and therapeutic strategies related to nitric-oxide
10. The role of arginine: Nitric oxide pathway in circulatory shock
11. Synergistic septicemic action of the Gram-positive bacterial cell wall components peptidoglycan and lipoteichoic acid in the pig in vivo
12. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model
13. Peptidoglycan and lipoteichoic acid modify monocyte phenotype in human whole blood
14. Biological activities of lipoteichoic acid and peptidoglycan teichoic-acid of Bacillus subtilis-168 (Marburg)
15. Mechanism of Gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure
16. Studies on lytic enzymes toward cariogenic streptococci. 9. Isolation of bacteriolytic endopeptidase from a strain of Cytophaga and its application to preparation of hydrosoluble polysaccharide peptide from Staphylococcus epidermidis peptidoglycan
17. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans
18. Studies on endo-β-acetylglucosaminidase, staphylolytic peptidase, and N-acetylmuramyl-l-alanine amidase in lysostaphin and from Staphylococcus aureus
19. Past, present and future of the synthetic immunoadjuvant Mdp and its analogs
20. Bioactive conformations of small peptides - A method for selection of candidates based on conformations of active and inactive analogs and its application to muramyl dipeptide
21. Molecular analysis of lipid macroamphiphiles by hydrophobic interaction chromatography
22. Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae Atcc9790 for cytokine-inducing, anti-tumour and antigenic activities
23. Molecules from Staphylococcus aureus that bind Cd14 and stimulate innate immune responses
24. Assessment of nonprotein impurities in potential vaccine proteins produced by Bacillus subtilis
25. Activation of arachidonic-acid metabolism in mouse macrophages by bacterial amphiphiles
26. The alanine ester substitution of lipoteichoic acid (Lta) in Staphylococcus aureus
27. On the basic structure of poly(glycerophosphate) lipoteichoic acids
28. Lipoteichoic acids: A new class of bacterial antigen
29. Peptidoglycan types of bacterial cell walls and their taxonomic implications
30. Separation and quantification of muropeptides with high-performance liquid-chromatography
31. Role of nitric oxide synthase in the circulatory failure and organ injury in a rodent model of Gram-positive shock
32. Nosocomial blood stream infections. Secular trends in rates, mortality, and contribution to total hospital deaths
33. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis
34. Definition of the role of enterococcus in intraabdominal infection: Analysis of a prospective randomised trial
35. Pathogenicity of enterococci in a rat model of fecal peritonitis
36. A cell wall component from pathogenic and nonpathogenic Gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat
37. Combination immunotherapy which neutralises the effects of TNF alpha and IL-1 beta attenuates the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat
38. Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides
39. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein
40. CD14 and the innate recognition of bacteria
41. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
42. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
43. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
44. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharides
45. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses
46. Binding of bacterial peptidoglycan to CD14
47. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures
48. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
49. Peptidoglycan and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2
50. Antibody synthesis to peptidoglycan polysaccharide after ischemic injury of the intestine
51. The significance of endotoxin release in experimental and clinical sepsis in surgical patients - Evidence for antibiotic-induced endotoxin release
52. Antibiotic induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: Quantitative measurements and biological reactivities